| Study | Reason for exclusion |
|---|---|
| Alaibac 2005 | Case report of a patient with SPTCL treated with autologous PBSCT and review of published cases of SPTCL treated with this therapeutic approach. |
| Bertz 2002 | Study not randomised, not controlled. CTCL not included. |
| Burt 2000 | Case report of a patient with MF treated with allogeneic haematopoetic stem cell transplantation. |
| Chanan‐Khan 2004 | Case report of a patient with alpha/beta hepatosplenic T‐cell non‐Hodgkin lymphoma treated with allogeneic stem cell transplantation and donor lymphocyte infusion. |
| Corradini 2006 | Patients with MF/SS or cutaneous lymphomas were excluded from the study. |
| Cudillo 2009 | Case report of a patient with SS. |
| Duarte 2008 | Review article of published data on the use of autologous and allogeneic HSCT for CTCL. |
| Duarte 2010 | Study not randomised, not controlled. Retrospective analysis on the use of alloHSCT in a series of patients with advanced‐stage MF/SS. |
| Duvic 2010 | Study not randomised, not controlled. Single‐arm study observing safety and efficacy of total skin electron beam with allogeneic stem cell transplantation in 19 patients with CTCL. |
| Fijnheer 2003 | Case report of a patient with cutaneous CD30‐negative large T‐cell lymphoma treated with non‐myeloablative allogeneic peripheral stem cell transplantation. |
| Gabriel 2007 | Case report of a patient with a cytotoxic variant of MF treated with autologous stem cell transplantation followed by reduced‐intensity sibling allogeneic stem cell transplantation in relapsed disease. |
| Ghobrial 2005 | Study not randomised, not controlled. Retrospective analysis of diverse therapeutic approaches in 21 patients with SPTCL. |
| Guitart 2002 | Study not randomised, not controlled. Case series of three patients with refractory tumour stage MF treated with allogeneic HLA‐matched sibling transplantation after cytoreductive chemotherapy and total‐body irradiation. |
| Hamadani 2008 | CTCL not included. |
| Hathaway 2007 | Study not randomised, not controlled. Case series of two patients with SPTCL treated with corticosteroids and denileukin diftitox. |
| Herbert 2004 | Study not randomised, not controlled. Case series of three patients with advanced, refractory (N = 2) or transformed (N = 1) CTCL who underwent reduced‐intensity allogeneic stem cell transplantation. |
| Hoff 2008 | Case report of a patient with treatment‐refractory MF treated with non‐myeloablative allogeneic stem cell transplantation. |
| Horwitz 2008 | Review article discussing the importance of stage‐based therapy in MF and SS. |
| Ichii 2006 | Case report of a patient with SPTCL treated with allogeneic PBSCT. |
| Kahata 2008 | Case report of a patient with SS with large cell transformation treated with reduced‐intensity allogeneic bone marrow transplantation. |
| Knobler 2001 | Review article about clinical trials of extracorporeal photochemoimmunotherapy (ECP) in CTCL. |
| Knobler 2002 | Case report of a patient with CTCL treated with ECP, including an update on current status of ECP treatment. |
| Koch 2009 | Case report of a patient with cutaneous gamma/delta T‐cell lymphoma treated with allogeneic stem cell transplantation. |
| Majhail 2005 | Review article on the current status of haematopoetic stem cell transplantation in CTCL. |
| Masood 2002 | Case report of a patient with stage IVA MF treated with HLA‐matched allogeneic stem cell transplantation. |
| Molina 1999 | Case report of a patient with refractory SS treated with allogeneic unrelated donor bone marrow transplantation. |
| Molina 2005 | Study not randomised, not controlled. Retrospective analysis of eight patients with advanced MF/SS evaluating the outcome of allogeneic haematopoetic stem cell transplantation in these patients. |
| Mukai 2003 | Case report of a patient with SPTCL treated with high‐dose chemotherapy and total body irradiation with autologous peripheral stem cell rescue. |
| Nakahashi 2009 | Case report of a patient with refractory SPTCL treated with autologous peripheral blood stem cell transplantation. |
| Nishio 2000 | Case report of a patient with CD30‐negative T‐cell lymphoma treated with autologous peripheral blood stem cell transplantation. |
| Okada 2010 | Case report of a patient with MF treated with allogeneic bone marrow transplantation followed by relapse with a therapy‐resistant immunophenotypic change (CD4+ to CD8+). |
| Perez‐Persona 2006 | Case report. Patient did not fit inclusion criteria (aged 15). |
| Poligone 2010 | Review article about the use of innovative therapies for CTCL. |
| Rook 1994 | Review article on the general use of extracorporeal photopheresis. |
| Russell‐Jones 2001 | Study not randomised, not controlled. Single‐arm study observing the efficacy of autologous peripheral stem cell transplantation in nine patients with MF. |
| Shustov 2010 | Study not randomised, not controlled. Single‐arm study evaluating the outcome after non‐myeloablative alloHSCT for patients with advanced T‐cell and NK‐cell lymphoma. |
| Soligo 2003 | Study not randomised, not controlled. Case series of three patients with advanced MF treated with HLA‐identical non‐myeloablative allogeneic stem cell transplantation. |
| Taylor 1992 | Review article on the general use of extracorporeal photochemotherapy. |
| Tsuji 2010 | Case series of two patients with MF treated by reduced‐intensity cord blood transplantation. |
| Wu 2009 | Meta‐analysis of 39 patients to compare the outcome of allogeneic versus autologous stem cell transplantation in patients with MF/SS. |
| Zain 2010 | Review article about epigenetic therapies in cutaneous T‐cell lymphomas. |
Only studies thought to be potentially suitable for this review are mentioned in this table.
CTCL ‐ cutaneous T‐cell lymphoma
HLA ‐ human leukocyte antigen
HSCT ‐ haematopoetic stem cell transplantation
MF ‐ Mycosis fungoides
PBSCT ‐ peripheral blood stem cell transplantation
SPTCL ‐ subcutaneous panniculitis‐like T‐cell lymphoma
SS ‐ Sézary syndrome